Author: BEF

by
Boomer Esiason Foundation, CF News
March 19, 2019

Texas Christian University senior Jake Kirkpatrick has been named the recipient of the 2010 Rimington Trophy. The Trophy, named for Boomer Esiason Foundation President David B. Rimington, is awarded annually to the most outstanding center in NCAA Division I-A football. Kirkpatrick was previously a finalist for...

by
CF News, Therapies
March 19, 2019

Sep 24, 2013 SOURCE: ABBVIE  NORTH CHICAGO, Ill. and MECHELEN, Belgium, Sept. 24, 2013 /PRNewswire/ -- Galapagos NV (Euronext: GLPG) and AbbVie (NYSE: ABBV) announced today that they have entered into a global alliance to discover, develop and commercialize novel potentiator and combination therapies in cystic fibrosis...

by
CF Community, CF News, Therapies
March 19, 2019

A dry powder form of the antibiotic TOBI - TOBI Podhaler (tobramycin inhalation powder) - used to treat lung infections caused by the bacteria Pseudomonas aeruginosa has been approved by the US Food and Drug Administration (FDA). People with CF ages six and older who have Pseudomonas aeruginosa  and...

by
CF News, Therapies
March 19, 2019

Digestive Care, Inc. (DCI), announced it has received U.S. Food and Drug Administration (FDA) approval of its new drug application for PERTZYE™, indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. PERTZYE is a unique pancreatic enzyme product containing bicarbonate-buffered...